Showing results (191-200 of 211) with videos related to

Sort By:
Pageof 22
Journal of the National Cancer Institute|November 15, 1989
In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanomaK D Griffith, E J Read, J A Carrasquillo, et al.
British Journal of Haematology|November 28, 2001
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-backR Nakamura, E Bahceci, E J Read, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1989
Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanomaB Fisher, B S Packard, E J Read, et al.
Blood|July 1, 1993
Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantationR R Quinones, R H Gutierrez, P A Dinndorf, et al.
International Journal of Geriatric Psychiatry|July 12, 2002
The relation of White Matter Hyperintensities to implicit learning in healthy older adultsH J Aizenstein, R D Nebes, C C Meltzer, et al.
Blood|June 1, 1997
Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivoR V Emmons, S Doren, J Zujewski, et al.
Cytotherapy|February 6, 2003
Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequencesH M Khuu, H Cowley, V David-Ocampo, et al.
Cancer|March 15, 1994
Localization of 111indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with responseB A Pockaj, R M Sherry, J P Wei, et al.
Science Advances|May 4, 2019
Behavioral and epigenetic consequences of oxytocin treatment at birthW M Kenkel, A-M Perkeybile, J R Yee, et al.
Cytotherapy|December 11, 2002
Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantationS R Solomon, T Tran, C S Carter, et al.
Pageof 22